U.S. STOCKS ON THE MOVE-premarket

Amicus Therapeutics

29/09/2023 13:03

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
 U.S. stock index futures advanced on Friday as Treasury yields eased from
multi-year highs and powered gains in growth stocks, while investors awaited a
crucial inflation metric to assess the outlook for the Federal Reserve's
monetary policy. .N 
    
    At 7:51 ET, Dow e-minis  1YMc1  were up 0.40% at 34,026. S&P 500 e-minis
 ESc1  were up 0.37% at 4,353.5, while Nasdaq 100 e-minis  NQc1  were up 0.52%
at 14,937.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Local Bounti  LOCL.K , up 11.1%
 ** Nike  NKE , up 9.7%
 ** Black Mountain Acquisition  BMAC.K , up 9.5%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Torrid Holdings  CURV.K , down 9.3%
 ** American Strategic Investment  NYC , down 5%
 ** Flotek Industries  FTK , down 4.5%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** BTC Digital  BTCT.O , up 230.0%
 ** Blue Apron Holdings  APRN.O , up 133.7%
 ** OpGen  OPGN.O , up 129.4%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Glimpse Group  VRAR.O , down 42.5%
 ** Tonix Pharmaceuticals Holding  TNXP.O , down 30.8%
 ** Vaccinex  VCNX.O , down 29.8%
 
 
 ** Nike Inc  NKE.N : up 9.7% premarket
 BUZZ - European sportswear makers gain after upbeat Nike results  urn:newsml:reuters.com:*:nL8N3B51UU 
 BUZZ - Gains on Q1 profit beat, analysts hold mixed views  urn:newsml:reuters.com:*:nL4N3B51IK
    
 ** Amicus Therapeutics Inc  FOLD.O : up 3.4% premarket
 BUZZ - J.P.Morgan sees Amicus Therapeutics soaring 60% by end-2024  urn:newsml:reuters.com:*:nL4N3B51HZ
    
 ** FedEx Corp  FDX.N : up 0.6% premarket
 BUZZ - HSBC initiates FedEx coverage with 'buy' rating  urn:newsml:reuters.com:*:nL4N3B51RV

 (Rajarshi Roy and Abhinav Parmar)
 ((Abhinav.Parmar@thomsonreuters.com))